Saturday 17 October 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 44.1%, free cash flow grew 141.2% and total debt rose 42.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

121.84 0.33 +0.27%

Follow HALO

Alert me

Market cap: $13.8B
P/E: 34.6×
Fwd P/E: 10.6×
Dividend yield: —
F-score: 5/9
Altman Z: 3.46
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	173.67%	99.40%	153.59%	124.50%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	5	5	8
ROA Full definition →	17.86%	14.33%	13.81%	27.45%
ROIC Full definition →	18.13%	15.64%	14.31%	35.11%
Return on Tangible Assets Full definition →	61.47%	48.31%	43.39%	105.78%
Average Days of Receivables Full definition →	100.00	110.82	115.33	101.62
Free Cash Flow per Share Full definition →	6.87	5.65	5.38	6.31
Free Cash Flow Full definition →	806.22	667.65	644.59	739.68
Capital Expenditures Full definition →	(12.37)	(9.76)	(6.97)	128.68
Other line items
Cash ROIC Full definition →	31.98%	24.89%	27.61%	27.23%
Accounts Receivable Turnover Full definition →	4.31	3.96	3.73	3.93
Accounts Payable Turnover Full definition →	13.83	15.19	14.69	13.84
Inventory Turnover Full definition →	1.84	1.62	1.44	1.21
Average Days of Payables Full definition →	29.47	19.82	33.34	29.19
Days of Inventory on Hand Full definition →	171.17	218.58	281.56	353.10
Tax Rate Full definition →	(0.29)	(0.31)	(0.32)	(0.20)
Research and Development Expense of Revenue Full definition →	23.28%	25.00%	26.23%	5.63%
Selling, General and Administrative Expense of Revenue Full definition →	14.30%	14.76%	14.83%	13.86%
Share Based Compensation of Revenue Full definition →	3.79%	3.81%	3.69%	3.74%
Interest Coverage Full definition →	29.41	26.79	25.87	41.53
Operating CF/Net income Full definition →	1.98	1.94	2.06	1.03
Depreciation/Fixed assets Full definition →	1.45	1.31	1.12	1.17
Capex/Depreciation Full definition →	(0.10)	(0.09)	(0.08)	1.54
Revenue per Share Full definition →	14.19	12.77	11.65	10.60
Operating CF per Share Full definition →	6.98	5.73	5.44	5.21
Capex per Share Full definition →	(0.11)	(0.08)	(0.06)	1.10
Capex to Sales Full definition →	0.01	0.01	0.01	(0.10)

Show all line items

Columns are period end dates

Stockrow Weekly